Cited by 341SARS-CoV-2 and COVID-19 ResearchT-cell and B-cell ImmunologyImmune responses and vaccinations

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Open access

Sokal, Aurélien, Chappert, Pascal, Barba-Spaeth, Giovanna, Roeser, Anais, Fourati, Slim, Azzaoui, Imane, Vandenberghe, Alexis, Fernandez, Ignacio, Meola, Annalisa, Bouvier-Alias, Magali, Crickx, Etienne, Beldi-Ferchiou, Asma, Hue, Sophie, Languille, Laetitia, Michel, Marc, Baloul, Samia, Noizat-Pirenne, France, Luka, Marine, Mégret, Jérôme, Ménager, Mickaël, Pawlotsky, Jean-Michel, Fillatreau, Simon, Rey, Felix A., Weill, Jean-Claude, Reynaud, Claude-Agnès, Mahévas, Matthieu·2021·Cell

DOI 10.1016/j.cell.2021.01.050PMC PMC7994111

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

Memory B cells play a fundamental role in host defenses against viruses, but to date, their role has been relatively unsettled in the context of SARS-CoV-2. We report here a longitudinal single-cell and repertoire profiling of the B cell response up to 6 months in mild and severe COVID-19 patients. Distinct SARS-CoV-2 spike-specific activated B cell clones fueled an early antibody-secreting cell burst as well as a durable synchronous germinal center response. While highly mutated memory B cells, including pre-existing cross-reactive seasonal Betacoronavirus-specific clones, were recruited early in the response, neutralizing SARS-CoV-2 RBD-specific clones accumulated with time and largely contributed to the late, remarkably stable, memory B cell pool. Highlighting germinal center maturation, these cells displayed clear accumulation of somatic mutations in their variable region genes over time. Overall, these findings demonstrate that an antigen-driven activation persisted and matured up to 6 months after SARS-CoV-2 infection and may provide long-term protection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2021.01.050

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Fast, sensitive and accurate integration of single-cell data with Harmony
Korsunsky, I., Millard, N., Fan, J., Slowikowski, K., Zhang, F., Wei, K., Baglaenko, Y., Brenner, M., Loh, P.-R., & Raychaudhuri, S. (2019) · Nature Methods · doi:10.1038/s41592-019-0619-0 · Cited by 10,488
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656 · cited 2×
“This is also consistent with recent results showing in a large cohort of patients that SARS-CoV-2 antigen-speciﬁc MBCs persist up to 8 months after infection (Dan et al., 2021).”
BackgroundResult
PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase
D’Hulst, G., Soro-Arnaiz, I., Masschelein, E., Veys, K., Fitzgerald, G., Smeuninx, B., Kim, S., Deldicque, L., Blaauw, B., Carmeliet, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13889-6 · Cited by 2,310
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2380-z · Cited by 1,667 · cited 1×
“Furthermore, early reports have shown potentially defective GC formation in S-CoV patients in the intensive care unit (Kaneko et al., 2020) and predominantly near-germline anti-SARS-CoV-2 neutralizing antibodies (Ju et al., 2020; Nielsen et al., 2020; Rob-biani et al., 2020).”

Show all 77 references

Sorted by citations

Items 201–300 of 341

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein
Manfredi, F., Chiozzini, C., Ferrantelli, F., Leone, P., Giovannelli, A., Sanchez, M., & Federico, M. (2022) · Vaccines · doi:10.3390/vaccines10071060 · Cited by 7
Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response
Lin, T., Huang, P.-H., Liao, B., Chao, T., Tsai, Y., Chang, S., Chang, S., & Chen, H. (2022) · Vaccines · doi:10.3390/vaccines10111839 · Cited by 9
Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics
Broketa, M., Sokal, A., Mor, M., Canales-Herrerías, P., Perima, A., Meola, A., Fernández, I., Iannascoli, B., Chenon, G., Vandenberghe, A., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.166602 · Cited by 10
Self-citation
SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination
Moore, T., Hossain, R., Doores, K. J., Shankar‐Hari, M., & Fear, D. J. (2022) · Viral Immunology · doi:10.1089/vim.2022.0013 · Cited by 7
PD-1 checkpoint blockade disrupts CD4 T cell regulated adaptive B cell tolerance to foreign antigensPreprint
Dufaud, C. R., Shuparski, A. G., Higgins, B., McHeyzer‐Williams, L. J., & McHeyzer‐Williams, M. G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.10.447979 · Cited by 5
Immune escape of SARS-CoV-2 Omicron variant from mRNA vaccination-elicited RBD-specific memory B cellsPreprint
Sokal, A., Broketa, M., Meola, A., Spaeth, G. B., Fernández, I., Fourati, S., Azzaoui, I., Selle, A. D. L., Vandenberghe, A., Roeser, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.21.473528 · Cited by 7
Self-citation
T-bet+ B Cells in Humans: Protective and Pathologic Functions
Nellore, A., Zumaquero, E., & Seifert, M. E. (2023) · Transplantation · doi:10.1097/tp.0000000000004889 · Cited by 6
A rare B cell clonotype imprinted by ancestral SARS-CoV-2 develops cross-sarbecovirus neutralization in immune recalls
Chen, X., Li, L., Du, R., Wang, Z., Li, Y., Sun, Y., Qin, R., Feng, H., Hu, L., Chen, X., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115964 · Cited by 6
Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19
Pink, I., Hennigs, J. K., Ruhl, L., Sauer, A., Boblitz, L., Huwe, M., Fuge, J., Falk, C. S., Pietschmann, T., de Zwaan, M., et al. (2023) · Infection · doi:10.1007/s15010-023-02114-8 · Cited by 7
Kinetics and persistence of anti‐SARS‐CoV‐2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort
Šošić, L., Paolucci, M., Duda, A., Hasler, F., Walton, S. M., Kündig, T. M., & Johansen, P. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.583 · Cited by 5
Hybrid immunity by two COVID‐19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2
Almanzar, G., Koosha, K., Vogt, T., Stein, A., Ziegler, L., Asam, C., Weps, M., Schwägerl, V., Richter, L. M., Hepp, N., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29739 · Cited by 6
Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants
Lunderberg, J. M., Dutta, S., Collier, A.-R. Y., Lee, J.-S., Hsu, Y., Wang, Q., Zheng, W., Hao, S., Zhang, H., Feng, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1032574 · Cited by 7
Induction of cross-reactive antibody responses against the RBD domain of the spike protein of SARS-CoV-2 by commensal microbiotaPreprint
Ninnemann, J., Budzinski, L., Bondareva, M. A., Witkowski, M., Angermair, S., Kreye, J., Durek, P., Reincke, S. M., Sánchez-Sendín, E., Yilmaz, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.08.455272 · Cited by 6
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2Preprint
Feng, Y., Yuan, M., Powers, J. M., Hu, M., Munt, J. E., Arunachalam, P. S., Leist, S. R., Bellusci, L., Adams, L. E., Sundaramurthy, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.19.524784 · Cited by 6
Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody
Chang, Y.-H., Hsu, M., Chen, W.-N., Wu, M., Kong, W., Lu, M. J., Huang, C.-H., Chang, F.-J., Chang, L., Tsai, H.-Y., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.179726 · Cited by 5
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections
Fournier, M., Vanderkerken, M. A., Dorgham, K., Bastard, P., Ahouzi, O., Duquerroy, S., Nguyen, N. P. T., Broutin, M., Charlet, M., Vandenberghe, A., et al. (2026) · Cell · doi:10.1016/j.cell.2026.04.013 · Cited by 9
Self-citation
Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers
Oyebanji, O. A., Sundheimer, N., Ragavapuram, V., Wilson, B. M., Abul, Y., Gravenstein, S., Bosch, J., King, C. L., & Canaday, D. H. (2024) · GeroScience · doi:10.1007/s11357-024-01215-y · Cited by 5
SARS-CoV-2 RBD-Specific Antibodies Induced Early in the Pandemic by Natural Infection and Vaccination Display Cross-Variant Binding and Inhibition
Walker, M. R., Podlekareva, D. N., Johnsen, S., Leerhøy, B., Fougeroux, C. E., Søgaard, M., Salanti, A., Ditlev, S. B., & Barfod, L. K. (2022) · Viruses · doi:10.3390/v14091861 · Cited by 5
RETRACTED: The pathogenicity of COVID-19 and the role of pentraxin-3: An updated review study
Margiana, R., Sharma, S. K., Khan, B. I., Alameri, A. A., Opulencia, M. J. C., Hammid, A. T., Hamza, T. A., Хамракулович, Б. Ш., Abdelbasset, W. K., & Jawhar, Z. H. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154128 · Cited by 5
Retracted
Identification of B cell subsets based on antigen receptor sequences using deep learning
Lee, H., Shin, K., Lee, Y., Lee, S., Lee, S., Lee, E., Kim, S. W., Shin, H. Y., Kim, J. H., Chung, J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1342285 · Cited by 7
The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
Dhawan, M. K., Thakur, N., Sharma, M. K., & Rabaan, A. A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117936 · Cited by 5
The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal
Tosta, E. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00014 · Cited by 5
Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection
Guihot, A., Plu, I., Soulié, C., Rousseau, A., Nakid-Cordero, C., Dorgham, K., Parizot, C., Litvinova, E., Mayaux, J., Malet, I., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844727 · Cited by 5
Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients
Wiedemann, A., Pellaton, C., Dekeyser, M., Guillaumat, L., Déchenaud, M., Krief, C., Lacabaratz, C., Grimbert, P., Pantaleo, G., Lévy, Y., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.978764 · Cited by 6
A Rapid Method for Detection of Antigen-Specific B Cells
Vakhitova, M. T., Myshkin, M. Y., Staroverov, D. B., Shagina, I. A., Izraelson, M., Tverdova, N., Britanova, O. V., & Merzlyak, E. M. (2023) · Cells · doi:10.3390/cells12050774 · Cited by 5
Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine
Wong, M., Liu, J. T., Budylowksi, P., Yue, F. Y., Li, Z., Rini, J. M., Carlyle, J. R., Zia, A., Ostrowski, M., & Martín, A. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.108963 · Cited by 6
Persistence and baseline determinants of seropositivity in health care workers up to nine months after COVID-19Preprint
Dobaño, C., Ramirez, A., Alonso, S., Vidal‐Alaball, J., Ruiz‐Olalla, G., Vidal, M., Rubio, R., Cascant, E., Parras, D., Melero, N. R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-142984/v1 · Cited by 5
Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individualsPreprint
Sokal, A., Spaeth, G. B., Fernández, I., Broketa, M., Azzaoui, I., Selle, A. D. L., Vandenberghe, A., Fourati, S., Roeser, A., Meola, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.17.448459 · Cited by 5
Self-citation
Omicron BA.1 breakthrough infection drives long-term remodeling of the memory B cell repertoire in vaccinated individualsPreprint
Sokal, A., Spaeth, G. B., Hunault, L., Fernández, I., Broketa, M., Meola, A., Fourati, S., Azzaoui, I., Vandenberghe, A., Lagouge-Roussey, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.27.525575 · Cited by 5
Self-citation
Deep profiling of antigen-specific B cells from different pathogens identifies novel compartments in the IgG memory B cell and antibody-secreting cell lineagesPreprint
Claireaux, M. A. F., Elias, G., Kerster, G., Kuijper, L., Duurland, M., Paul, A., Burger, J., Poniman, M., Olijhoek, W., de Jong, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.19.572339 · Cited by 5
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination
Kummer, L. Y. L., Kuijper, L. H., Blanco, L. F., Bos, A. V., Kreher, C., Verstegen, N. J. M., Duurland, M. C., Konijn, V. A. L., Jorritsma, T., Tempert, M., et al. (2025) · RMD Open · doi:10.1136/rmdopen-2025-005724 · Cited by 5
The seven enigmas of SARS-CoV-2: From the past to the future
Andreakos, E., Arkin, L. M., Bastard, P., Bolze, A., Borghesi, A., Brodin, P., Casanova, J., Casari, G., Cobat, A., Drolet, B. A., et al. (2025) · Journal of Human Immunity · doi:10.70962/jhi.20250149 · Cited by 5
Memory B cell development in response to mRNA SARS-CoV-2 and nanoparticle immunization in mice
Wiatr, M., wang, Z., Canis, M., Hernandez, B., Gazumyan, A., Santos, G. S. S., Shawraz, S., lee, S., Bieniasz, P. D., Hatziioannou, T., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2527869123 · Cited by 4
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections
Quirk, G., Schoenle, M. V., Peyton, K. L., Uhrlaub, J. L., Lau, B., Liang, C.-Y., Burgess, J. L., Ellingson, K., Beitel, S. C., Romine, J. K., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02162-2 · Cited by 5
Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein
Li, D., Zhao, H., Liao, Y., Jiang, G., Cui, P., Zhang, Y., Yu, L., Fan, S., Li, H., & Li, Q. (2023) · Vaccines · doi:10.3390/vaccines11050963 · Cited by 4
Single‐cell transcriptomic analysis of B cells reveals new insights into atypical memory B cells in COVID‐19
García‐Vega, M., Llamas-Covarrubias, M. A., Loza, M., Reséndiz‐Sandoval, M., Hinojosa‐Trujillo, D., Melgoza-González, E. A., Valenzuela, O., Mata‐Haro, V., Hernández‐Oñate, M. Á., Soto‐Gaxiola, A., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29851 · Cited by 4
Mass‐Standardised Differential Antibody Binding to a Spectrum of SARS ‐ CoV ‐2 Variant Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4/5, BA.2.75 and BA.2.12.1 Variants—Antibody Immunity Endotypes
James‐Pemberton, P. H., Kohli, S., Twynham, J., Westlake, A. C., Antill, A., Hunt, J., Olkhov, R., & Shaw, A. M. (2025) · Immunology · doi:10.1111/imm.70083 · Cited by 5
Impact of SARS-CoV-2-specific memory B cells on the immune response after mRNA-based Comirnaty vaccine in seronegative health care workers
Vallejo, A., Vizcarra, P., Martín-Hondarza, A., Gómez-Maldonado, S., Häemmerle, J., Velasco, H., & Casado, J. L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1002748 · Cited by 4
Complementarity determining regions in SARS-CoV-2 hybrid immunity
Frans, G., Dillaerts, D., Dehaemers, T., Elslande, J. V., Leeuw, J. D., Boon, L., Maes, W., Callewaert, N., Calcoen, B., Ancheva, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1050037 · Cited by 3
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination
Casado, J. L., Vizcarra, P., Martín-Hondarza, A., Blasco, M., Platero, M. G., Häemmerle, J., Fernández-Escribano, M., & Vallejo, A. (2023) · Viruses · doi:10.3390/v15030627 · Cited by 4
To be remembered: B cell memory response against SARS‐CoV ‐2 and its variants in vaccinated and unvaccinated individuals
Ahmed, N., Athavale, A., Tripathi, A. H., Subramaniam, A., Upadhyay, S. K., Pandey, A. K., Rai, R. C., & Awasthi, A. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13345 · Cited by 4
Poor immune response to inactivated COVID-19 vaccine in patients with hypertension
Yang, L., Zhang, Z., Guo, Q., Yang, L., & Ren, H. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1329607 · Cited by 4
Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination
Najimi, N., Kadi, C., Elmtili, N., Seghrouchni, F., & Bakri, Y. (2024) · Human Antibodies · doi:10.3233/hab-230017 · Cited by 4
COVID-19: individual and herd immunity
Bach, J., Berche, P., Chatenoud, L., Costagliola, D. G., & Valleron, A. (2021) · Comptes Rendus Biologies · doi:10.5802/crbiol.41 · Cited by 4
Will the large‐scale vaccination succeed in containing the COVID‐19 pandemic and how soon?
Zhao, S., Sha, T., Xue, Y., Wu, C.-I., & Chen, H. (2021) · Quantitative Biology · doi:10.15302/j-qb-021-0256 · Cited by 4
Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients
Song, A., Jang, J., Lee, A., Min, S. Y., Lee, S. G., Kim, S., Shin, J., & Kim, J. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932909 · Cited by 4
Immune Dynamics Involved in Acute and Convalescent COVID-19 Patients
Silva-Junior, A. L., Oliveira, L. D. S., Belezia, N. C. T., Tarragô, A. M., Costa, A. G., & Malheiro, A. (2023) · Immuno · doi:10.3390/immuno3010007 · Cited by 4
SARS-CoV-2-specific memory B cells can persist in the elderly despite loss of neutralising antibodiesPreprint
Jeffery-Smith, A., Burton, A. R., Lens, S., Rees-Spear, C., Patel, M., Gopal, R., Muir, L., Aiano, F., Doores, K. J., Chow, J. Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.30.446322 · Cited by 4
Enhanced neutralization of SARS-CoV-2 XBB sub-lineages and BA.2.86 by a tetravalent COVID-19 vaccine boosterPreprint
Wang, X., Jiang, S., Ma, W., Li, X., Wei, K., Xie, F., Zhao, C., Zhao, X., Li, C., Qiao, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.14.557682 · Cited by 4
Dual dynamics of persistence and recruitment characterise the ACPA-expressing B cell response in rheumatoid arthritis
van de Wetering, R., Mujumdar, S., Slot, L. M., Kampstra, A. S. B., Kroos, S., Schopmeijer, R., Neppelenbroek, S., Fehres, C. M., Heemskerk, M. H. M., Scherer, H. U., et al. (2026) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2026.03.033 · Cited by 3
Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern
Facciuolo, A., van Kessel, J., Kroeker, A., Liao, M., Lew, J. M., Falzarano, D., Kelvin, A. A., Gerdts, V., & Napper, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1148255 · Cited by 4
Pre-existing humoral immunity and CD4+ T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination
Shen, C., Fu, Y.-C., Ho, T., Chen, P., Lee, N., Tsai, B., Tsai, P.-J., Ko, W., Liu, H., Cheng, C., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109342 · Cited by 3
Viable viruses in airborne particles detected during cough by participants with acute respiratory viral infections
Tay, G., Niazi, S., He, C., Morawska, L., Bell, S. C., Spann, K. M., & Ristovski, Z. (2025) · Journal of Hospital Infection · doi:10.1016/j.jhin.2025.07.005 · Cited by 3
Mechanisms Promoting Stability of B Cells
Kuan, V. L. S., & Chaudhuri, J. (2025) · Immunological Reviews · doi:10.1111/imr.70064 · Cited by 3
Duration of immunity following infection with moderately virulent ASFV
Friedrichs, V., Deutschmann, P., Wernike, K., Carrau, T., Beer, M., Blome, S., & Schäfer, A. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014018 · Cited by 3
Antibodies as drugs—a Keystone Symposia report
Cable, J., Saphire, E. O., Hayday, A., Wiltshire, T. D., Mousa, J. J., Humphreys, D. P., Breij, E. C. W., Bruhns, P., Broketa, M., Furuya, G., et al. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14915 · Cited by 3
Self-citation
Systems biology of B cells in COVID-19
Woodruff, M. C., Faliti, C. E., & Sanz, I. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101875 · Cited by 3
Immunologic mediators profile in COVID-19 convalescence
Silva-Junior, A. L., de Oliveira, L. S., Dias, S., Costa, T. C. C., Xábregas, L. A., Alves-Hanna, F. S., Abrahim, C. M. M., Neves, W. L. L., Crispim, M. A. E., Toro, D. M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71419-x · Cited by 3
Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection
Kuijper, L. H., Kreher, C., Elias, G., Claireaux, M. A. F., Kerster, G., Bos, A. V., Duurland, M. C., Konijn, V. A. L., Paul, A., de Jong, N., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1505719 · Cited by 6
Induction of Cross-Reacting Antibodies Against the COVID-19 by BCG Vaccination in the Mouse Model
Rahali, N., & Bahloul, C. (2022) · Current Microbiology · doi:10.1007/s00284-022-02971-w · Cited by 3
Heterogeneous immunological recovery trajectories revealed in post-acute COVID-19Preprint
Su, Y., Yuan, D., Chen, D. G., Wang, K., Choi, J., Dai, C. L., Hong, S., Zhang, R., Xie, J., Li, S., et al. (2021) · medRxiv · doi:10.1101/2021.03.19.21254004 · Cited by 3
Characterization of SARS-CoV-2 Convalescent Patients’ Serological Repertoire Reveals High Prevalence of Iso–RBD AntibodiesPreprint
Curtis, N. C., Shin, S., Hederman, A. P., Connor, R. I., Wieland‐Alter, W., Ionov, S., Boylston, J. A., Rose, J., Sakharkar, M., Dorman, D. B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.08.556349 · Cited by 4
B cells imprinted by ancestral SARS-CoV-2 develop pan-sarbecovirus neutralization in immune recallsPreprint
Chen, X., Li, L., Du, R., Wang, Z., Li, Y., Sun, Y., Qin, R., Feng, H., Hu, L., Chen, X., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.13.618110 · Cited by 3
Characterization of a heterogenous activated B cell compartment arising early after antigen exposure preceding long-lived memory B cell formationPreprint
Blanco, L. F., Kuijper, L. H., Kummer, L. Y. L., Verstegen, N. J. M., Bos, A. V., Claireaux, M. A. F., Duurland, M. C., Jorritsma, T., Steenhuis, M., Kerster, G., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.22.629610 · Cited by 3
Convergent and clonotype-enriched mutations in the light chain drive affinity maturation of a public antibodyPreprint
Rao, V., Sapse, I. A., Cohn, H., Yoo, D.-K., Tong, P., Clark, J., Bozarth, B., Chen, Y., Srivastava, K., Singh, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.07.642041 · Cited by 3
Long-Term Dynamics of SARS-CoV-2 Variant-Specific Neutralizing Antibodies Following mRNA Vaccination and Infection
Vaňová, V., Náhliková, J., Ličková, M., Slavíková, M., Kajanová, I., Lukáčiková, Ľ., Sabo, M., Rádiková, Ž., Pastoreková, S., & Klempa, B. (2025) · Viruses · doi:10.3390/v17050675 · Cited by 3
Imprints of somatic hypermutation on B-cell receptor immunoglobulins post-infection versus post-vaccination against SARS-CoV-2
Vlachonikola, E., Pechlivanis, N., Karakatsoulis, G., Degano, M., Psomopoulos, F. E., Crisanti, A., Tonon, G., Ghia, P., Σταματόπουλος, Κ., Lavezzo, E., et al. (2025) · ImmunoHorizons · doi:10.1093/immhor/vlaf021 · Cited by 3
Patients with Trichinella spiralis infection display unmodified antigen-specific immune response to SARS-CoV-2
Mitić, I., Glamočlija, S., Ilić, N., Sabljić, L., Tomić, S., Gruden‐Movsesijan, A., & Sofronić‐Milosavljević, L. (2025) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760250044 · Cited by 3
Heterogeneous Activated B Cell Compartments Arising Early and Transiently After SARS‐CoV‐2 Vaccination
Blanco, L. F., Kuijper, L. H., Kummer, L. Y. L., Verstegen, N. J. M., Bos, A. V., Claireaux, M. A. F., Duurland, M. C., Jorritsma, T., Steenhuis, M., Kerster, G., et al. (2026) · European Journal of Immunology · doi:10.1002/eji.70165 · Cited by 2
Demultiplexing Ig repertoires by parallel mRNA/DNA sequencing shows major differential alterations in severe COVID-19
Pascal, V., Dupont, M., de Rouault, P., Rizzo, D., Delphine Rossille, A., Jeannet, R., Daix, T., François, B., Genebrier, S., Cornic, M., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106260 · Cited by 4
An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant
Uraki, R., Kiso, M., Ito, M., Yamayoshi, S., Halfmann, P., Jain, S., Suthar, M. S., Lopes, T. J. S., Jounai, N., Miyaji, K., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105794 · Cited by 2
A Review on Role of Inflammation in Coronavirus Disease
Lotfi, A., Hajian, P., Abbasi, L., Gargari, M. K., Fard, N. N. G., & Naderi, D. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303265274231204075802 · Cited by 2
Overview of the neutralizing antibody and memory B cell response kinetics in SARS-CoV-2 convalescent and/or mRNA vaccinated individuals.
Grigorova, I. (2021) · System Biology and Physiology Reports · doi:10.52455/sbpr.01.202103011 · Cited by 2
SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid conditionPreprint
Limoges, M.-A., Quenum, A., Chowdhury, M. M. H., Rexhepi, F., Namvarpour, M., Akbari, S. A., Rioux‐Perreault, C., Nandi, M., Lucier, J., Lemaire‐Paquette, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.13.535896 · Cited by 2
Spatial Morphoproteomic Features Predict Uniqueness of Immune Microarchitectures and Responses in Lymphoid FolliclesPreprint
Hu, T., Allam, M., Kaushik, V., Goudy, S. L., Xu, Q., Mudd, P. A., Manthiram, K., & Coskun, A. F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.05.574186 · Cited by 2
Studying the Humoral Response against SARS‐CoV‐2 in Cuban COVID‐19 Recovered Patients
Orosa-Vázquez, I., Díaz-Hernández, M., Rosales, Y. Z., Amada, K., Chang, J., Relova-Hernández, E., Tundidor, Y., Balbuena, H. R., Benítez, G. M., Rives, B. T., et al. (2024) · Journal of Immunology Research · doi:10.1155/2024/7112940 · Cited by 1
Memory B Cells Provide Long‐Term Protection to Vaccinated Kidney Transplant Recipients Against SARS‐CoV‐2 Variants
Espi, M., Charmetant, X., Benotmane, I., Lefsihane, K., Barateau, V., Gallais, F., Boulenouar, H., Ovize, A., Barbry, A., Bouz, C., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.70037 · Cited by 1
Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer
Marutescu, L. G., Enea, A. G., Antoniadis, N.-M., Neculae, M., Costea, D.-A., Popa, M., Dragu, E., Codrici, E., Ristoiu, V., Gălățeanu, B., et al. (2025) · Viruses · doi:10.3390/v17060848 · Cited by 1
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost
Lima, N. S., McCormick, L., Li, S., Wake, C., Subramanian, R., Spangler, A., Pinto, Y., Catalano, W. L., Henry, A. R., Laboune, F., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aeb9837 · Cited by 1
BCRInsight: an antibody language model to decode biological signals from BCR sequences
Zhao, H., Lou, S. K., Li, X., Gao, Y., Cao, W., Gu, H., & Zhang, F. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag154 · Cited by 1
Cytomics-driven insights for investigating host–pathogen interactions
Cossarizza, A., Mussini, C., Boraschi, D., & Tagliabue, A. (2026) · hLife · doi:10.1016/j.hlife.2026.04.003 · Cited by 1
Immune cell disorder in viral pneumonia
Zhang, Y., Li, F., Wang, L., Xu, D., Jing, J., Li, X., Liang, Q., & Li, Z. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08193-z · Cited by 1
Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS‐CoV‐2 Omicron Variants
Lv, H., Feng, Z., Teo, Q. W., Chen, C., Gopal, A. B., Choi, D., Tan, T. J. C., Tang, Y. S., Siu, L. Y.-L., Nourmohammad, A., et al. (2026) · Advanced Science · doi:10.1002/advs.76522 · Cited by 2
Examination of Common Coronavirus Antibodies in SARS-CoV-2-Infected and Uninfected Participants in a Household Transmission Investigation
Stumpf, M. M., Freeman, B. D., Mills, L. A., Lester, S. N., Chu, V. T., Kirking, H. L., Thornburg, N. J., & Killerby, M. E. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac212 · Cited by 1
Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection
Lei, Y., Chen, J., Wu, Q., Zhou, T., Zhang, B., Becich, M. J., Bisyuk, Y., Blecker, S., Chrischilles, E. A., Christakis, D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71820-2 · Cited by 2
Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19Preprint
Dobaño, C., Ramirez, A., Alonso, S., Vidal‐Alaball, J., Ruiz‐Olalla, G., Vidal, M., Rubio, R., Cascant, E., Parras, D., Melero, N. R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-142984/v2 · Cited by 1
Simultaneous and sequential multi-species coronavirus vaccinationPreprint
Peng, L., Fang, Z., Renauer, P. A., McNamara, A., Park, J. J.-Y., Lin, Q., Zhou, X., Dong, M. B., Zhu, B., Zhao, H., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.07.491038 · Cited by 1
Dissecting the impact of somatic hypermutation on SARS-CoV-2 neutralization and viral escapePreprint
Korenkov, M., Zehner, M., Cohen-Dvashi, H., Borenstein-Katz, A., Kottege, L., Janicki, H., Vanshylla, K., Weber, T., Gruell, H., Koch, M., et al. (2023) · bioRxiv · doi:10.1101/2023.05.09.539943 · Cited by 1
Autoreactive B cells in rheumatoid arthritis consist of activated CXCR3+ memory B cells and plasmablastsPreprint
Reijm, S., Kwekkeboom, J. C., Blomberg, N. J., Suurmond, J., van der Woude, D., Toes, R. E. M., & Scherer, H. U. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.19.538699 · Cited by 1
Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER ProjectPreprint
Chen, J., Lei, Y., Wu, Q., Zhou, T., Zhang, B., Becich, M. J., Bisyuk, Y., Blecker, S., Chrischilles, E. A., Christakis, D., et al. (2025) · medRxiv · doi:10.1101/2025.02.07.25321814 · Cited by 1
Mémoire immunitaire contre le SARS-CoV-2
Reynaud, C., Weill, J., Chappert, P., & Mahévas, M. (2021) · médecine/sciences · doi:10.1051/medsci/2021122
Self-citation
GESTÃO HOSPITALAR EM TEMPOS DE PANDEMIA: UM RELATO DE EXPERIÊNCIA
de Souza, S. E. F., Vieira, L. B., Souza, P. D. S., Soares, R. D. N., & Pereira, K. E. S. (2021) · doi:10.22533/at.ed.0622119109
Ценка риска деформации или взрыва резервуара при пожаре в резервуарном парке
Абрамов, Ю. А., & Евгеньевич, Б. А. (2006) · Вестник Харьковского национального автомобильно-дорожного университета
SARS-CoV-2 mRNA Vaccine Induces Robust Specific and Cross-Reactive IgG and Unequal Strain-Specific Neutralizing Antibodies in Naïve and Previously Infected RecipientsPreprint
Narowski, T. M., Raphel, K., Adams, L. E., Huang, J., Vielot, N. A., Jadi, R., deSilva, A. M., Baric, R. S., Lafleur, J., & Premkumar, L. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3879083
Clonal diversity determines persistence of SARS-CoV-2 epitope-specific T cell responsePreprint
Zornikova, K. V., Khmelevskaya, A. A., Sheetikov, S. A., Kiryukhin, D. O., Shcherbakova, O. V., Titov, A., Zvyagin, I. V., & Efimov, G. A. (2022) · medRxiv · doi:10.1101/2022.04.18.22273961
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations
Favalli, A., Favalli, E. G., Gobbini, A., Zagato, E., Bombaci, M., Maioli, G., Pesce, E., Donnici, L., Gruarin, P., Biggioggero, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873195
Estimation of COVID-19 Antibody (IgG) Titer Among Fully Vaccinated, Partially Vaccinated and Non-vaccinated Individuals in a Tertiary Care Hospital in Eastern India
Das, A., Neogi, A., Banerjee, P., Sengupta, S., & Kundu, M. (2022) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2022.05.1117
Reply to Focosi et al
Golding, H., & Khurana, S. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac744
What are the prospects for durable immune control?
Lelièvre, J., & Bauer, J. (2022) · Infectious Diseases Now · doi:10.1016/j.idnow.2022.09.010
Hide and seek with SARS-CoV-2: spike receptor-binding domain-specific memory B cells still recognize Omicron variant
Odak, I., Förster, R., & Bošnjak, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01192-8

Authors: Sokal, A., Chappert, P., Barba-Spaeth, G., Roeser, A., Fourati, S., Azzaoui, I., Vandenberghe, A., Fernandez, I., Meola, A., Bouvier-Alias, M., Crickx, E., Beldi-Ferchiou, A., Hue, S., Languille, L., Michel, M., Baloul, S., Noizat-Pirenne, F., Luka, M., Mégret, J., Ménager, M., Pawlotsky, J.-M., Fillatreau, S., Rey, F. A., Weill, J.-C., Reynaud, C.-A., & Mahévas, M.
Affiliations: Centre National de la Recherche Scientifique (FR)
Inserm (FR)
Université Paris-Est Créteil (FR)
Corresponding author: Mahévas, Matthieu
ORCID: Sokal, Aurélien
Chappert, Pascal
Roeser, Anais
Fourati, Slim
Azzaoui, Imane
Vandenberghe, Alexis
Meola, Annalisa
Beldi-Ferchiou, Asma
Languille, Laetitia
Michel, Marc
Ménager, Mickaël
Pawlotsky, Jean-Michel
Fillatreau, Simon
Rey, Felix A.
Weill, Jean-Claude
Reynaud, Claude-Agnès
Mahévas, Matthieu
Venue: Cell
Publisher: Elsevier BV
Published: 2021-03
Volume: 184
Issue: 5
Pages: 1201-1213.e14
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2021.01.050
PMC: PMC7994111
OpenAlex: W3128934913
Cited by: 340
References: 77
Citations by year: 2026: 25 · 2025: 36 · 2024: 36 · 2023: 58 · 2022: 107 · 2021: 76
FWCI: 21.93
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: other-oa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 368 d)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Cell (publishedVersion, other-oa)
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion, other-oa)
Funders: Agence Nationale de la Recherche
Fondation pour la Recherche Médicale
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords: SARS-CoV-2, COVID-19 pandemic, memory B cells, germinal center, antibody-secreting cells, spike protein, receptor binding domain, neutralizing antibodies, somatic hypermutation, cross-reactive antibodies, long-term immunity, B cell clones
MeSH terms: COVID-19, Adult, B-Lymphocytes, Flow Cytometry, Humans, Immunologic Memory, Lymphocyte Activation, Middle Aged, Severity of Illness Index, Germinal Center, Single-Cell Analysis, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks